Literature DB >> 31836834

Response to 'Comment on: 'You have got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration'.

Deanna J Taylor1, Lee Jones1, Alison M Binns1, David P Crabb2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31836834      PMCID: PMC7608279          DOI: 10.1038/s41433-019-0732-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.

To the Editor:

We thank Mr Gandhi for his letter that supports some of the key messages from our recent publication in Eye [1]. Namely, that dry AMD can have a devastating emotional impact on the patient, and that whilst eye clinics are overburdened and currently under immense pressures, more must be done to support people living with this lifelong condition, in terms of both practical and emotional support. Mr Gandhi makes several excellent observations in his letter and we simply elaborate on the evidence base supporting some of the pertinent points. First, the point that ‘many specialists convey information with lucidity, but their words can nonetheless be difficult to retain at the door’ highlights a key problem—that many individuals can feel overloaded with information at the point of diagnosis. Therefore, we are thrilled to hear about the design of a patient information booklet tailored for the specific purpose of directing patients to both local and national support. We hope other institutions follow this example. Another excellent resource to signpost individuals to for information and support is the Macular Society (www.macularsociety.org). We agree the ‘home situation’ of patients is of paramount importance. Interesting work is being carried out elsewhere on optimising risk assessment in the home for people with vision impairment [2, 3], although to our knowledge this tool has not as yet been applied to an AMD cohort. Another element to an individual’s home situation that can be key to patient support is that of the informal caregiver. Informal caregivers in wet AMD report a substantial psychological burden [4, 5] and we speculate that this is likely the case for caregivers of individuals with dry AMD, and that these individuals (described as ‘the hidden patients’) also require support. We also agree that referral to low-vision services should not just be for those with severe visual disability; our previous work [6-8] has shown that the performance of tasks relating to everyday visual function may be affected in some patients with intermediate AMD whilst visual acuity remains relatively preserved. Moreover, the subtle visual symptoms of AMD are often misunderstood [9]. We believe that the following quote from a participant with AMD in our study echoes Mr Gandhi’s very pertinent comment about patients desperately seeking personal autonomy: “It does take away your individuality of being you… You've got to rely on somebody else to do the things that you've always done.” We hope that people working within the field of dry AMD care consider these comments and the very relevant observations made by Mr Gandhi.
  2 in total

1.  Intravitreal treatment for geographic atrophy: coming soon to a patient near you?

Authors:  Christiana Dinah; Jamie Enoch; Arevik Ghulakhszian; Deanna J Taylor; David P Crabb
Journal:  Eye (Lond)       Date:  2021-05-18       Impact factor: 4.456

2.  A qualitative exploration of Australian eyecare professional perspectives on Age-Related Macular Degeneration (AMD) care.

Authors:  Isabelle Jalbert; Dian Rahardjo; Aryati Yashadhana; Gerald Liew; Bamini Gopinath
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.